Acute generalized exanthematous pustulosis induced by drugs with low-digestive absorption: Acarbose and nystatin;Pustulose exanthématique aiguë généralisée induite par des médicaments à faible absorption intestinale: L'acarbose et la nystatine

Annales de Dermatologie et de Venereologie

Volumn 130, Issue 4, 2003, Pages 439-442

  Poszepczynska Guigne E ^a   Viguier, M ^a   Assier, H ^b   Pinquier, L ^a   Hochedez, P ^a   Dubertret, L ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; DEXAMETHASONE SODIUM PHOSPHATE; DEXCHLORPHENIRAMINE MALEATE; GLUCOR; NYSTATIN; PARACETAMOL; PROPACETAMOL; STEROID; TROLAB;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL COUNT; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG TOLERABILITY; EOSINOPHIL; FEVER; FRANCE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NEUTROPHIL; PATCH TEST; PUSTULOSIS; RASH; TREATMENT OUTCOME;

ACARBOSE; ADULT; ANTIBIOTICS, ANTIFUNGAL; CANDIDIASIS, CUTANEOUS; DIABETES MELLITUS, TYPE 2; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; GENITAL DISEASES, MALE; HUMANS; HYPOGLYCEMIC AGENTS; INTESTINAL ABSORPTION; MALE; NYSTATIN; PATCH TESTS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0037701450     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991;127:1333-8.
2. Finan MC, Su WP, Li CY. Cutaneous findings in hairy cell leukemia. J Am Acad Dermatol 1984;11:788-97.
3. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol 2001;28:113-9.
4. Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985;40:111-8.
5. Lindstrom J, Tuomilehto J, Spengler M. Acarbose treatment does not change the habitual diet of patients with Type 2 diabetes mellitus. The Finnish Acarbose Study Group. Diabet Med 2000;17:20-5.
6. Andrade RJ, Lucena M, Vega JL, Torres M, Salmeron FJ, Bellot V et al. Acarbose-associated hepatotoxicity. Diabetes Care 1998;21:2029-30.
7. Kono T, Hayami M, Kobayashi H, Ishii M, Taniguchi S. Acarbose-induced generalized erythema multiforme. Lancet 1999;354:396-7.
8. Pareek SS. Nystatin-induced fixed eruption. Br J Dermatol 1980;103: 679-80.
9. Garty BZ. Stevens-Johnson syndrome associated with nystatin treatment. Arch Dermatol 1991;127:741-2.
10. Rosenberger A, Tebbe B, Treudler R, Orfanos CE. Acute generalized exanthematous pustulosis, induced by nystatin. Hautarzt 1998;49:492-5.
11. Kuchler A, Hamm H, Weidenthaler-Barth B, Kampgen E, Brocker EB. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases. Br J Dermatol 1997;137;808-11.
12. Wolkenstein P, Chosidow O, Flechet ML, Robbiola O, Paul M, Dume L et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Contact Dermatitis 1996;35:234-6.